Vivo Capital’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.6M | Hold |
|
|||||
|
2025
Q1 | $13.6M | Hold |
|
|||||
|
2024
Q4 | $22M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $6.16M | Hold |
|
|||||
|
2023
Q2 | $9.32M | Hold |
|
|||||
|
2023
Q1 | $7.27M | Hold |
|
|||||
|
2022
Q4 | $14.2M | Hold |
|
|||||
|
2022
Q3 | $14.1M | Hold |
|
|||||
|
2022
Q2 | $12.5M | Hold |
|
|||||
|
2022
Q1 | $15.5M | Sell |
|
|||||
|
2021
Q4 | $13.4M | Sell |
|
|||||
|
2021
Q3 | $16.9M | Sell |
|
|||||
|
2021
Q2 | $24.1M | Sell |
|
|||||
|
2021
Q1 | $41.5M | Hold |
|
|||||
|
2020
Q4 | $10.7M | Hold |
|
|||||
|
2020
Q3 | $4.23M | Hold |
|
|||||
|
2020
Q2 | $2.67M | Hold |
|
|||||
|
2020
Q1 | $1.71M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.61M | Hold |
|
|||||
|
2019
Q1 | $9.87M | Hold |
|
|||||
|
2018
Q4 | $12.2M | Hold |
|
|||||
|
2018
Q3 | $23.9M | Hold |
|
|||||
|
2018
Q2 | $32.9M | Hold |
|
|||||
|
2018
Q1 | $28.9M | Hold |
|
|||||
|
2017
Q4 | $40.6M | Sell |
|
|||||
|
2017
Q3 | $73.8M | Hold |
|
|||||
|
2017
Q2 | $77.5M | Hold |
|
|||||
|
2017
Q1 | $85.2M | Sell |
|
|||||
|
2016
Q4 | $89.1M | Sell |
|
|||||
|
2016
Q3 | $107M | Hold |
|
|||||
|
2016
Q2 | $77.4M | Hold |
|
|||||
|
2016
Q1 | $79.4M | Buy |
|